[DOI] [PubMed] [Google Scholar] 8.le Roux C.W., Aylwin S.J., Batterham R.L., Borg C.M., Coyle F., Prasad V
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
The bigger early jumps (2 to 4, 4 to 8) are offset by the lower starting point
Our team works closely with each patient to determine the most appropriate approach for achieving natural-looking, balanced results
I also wrote up the SURMOUNT-MAINTAIN dose-reduction trial separately, which addresses what most people want to know once they have hit their target weight
A provider who explains this reasoning clearly tends to leave patients with a more realistic sense of what a supervised plan actually involves